drugset / Trial / NCT00967174

Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

NCT00967174

Phase 1 Completed 42 enrolled McNeil AB
RandomizedSingle-groupDouble-blindScreening

Summary

An investigation on the cumulative skin irritation potential of a newly developed 25 mg nicotine patch. Evaluation of skin irritation of a newly developed 25 mg nicotine transdermal patch

Timeline

Start
2005-05
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 25 mg Topical
Subject SLS Unknown 0.1 % Topical

Indications

No indication recorded.